AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9743952
Drug: Intensive systemic
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive systemic and intrathecal chemotherapy without CRT in low-risk ALL patients
Trial: 3183370
Drug: xipamide 20
RxNorm normalized name: xipamide 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: xipamide 20 mg once a day
Trial: 22067185
Drug: Bupivacaine extended-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine extended-release 300 mg
Trial: 3087656
Drug: Astemizole 10
RxNorm normalized name: astemizole 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astemizole 10 mg orally per day
Trial: 3087656
Drug: Beclomethasone 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone 100 micrograms in each nostril twice daily
Trial: 17327934
Drug: Lansoprazole 15
RxNorm normalized name: lansoprazole 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 15 mg
Trial: 20384961
Drug: Ribavirin concentration
RxNorm normalized name: Ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ribavirin concentration <2 mg/L at day 29
Trial: 20384961
Drug: 12-week treatment
RxNorm normalized name: risedronate
DrugBank: Risedronic acid (DB00884)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 12-week treatment group with ribavirin concentration ≥2 mg/L
Trial: 20384961
Drug: 12-week treatment
RxNorm normalized name: risedronate
DrugBank: Risedronic acid (DB00884)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 12-week treatment group with ribavirin concentration <2 mg/L
Trial: 20384961
Drug: 24-week treatment
RxNorm normalized name: Weeks and Leo Complete Lice Treatment KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-week treatment group with ribavirin concentration ≥2 mg/L
Trial: 20384961
Drug: 24-week treatment
RxNorm normalized name: Weeks and Leo Complete Lice Treatment KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-week treatment group with ribavirin concentration <2 mg/L
Trial: 19055294
Drug: Zinc oxide
RxNorm normalized name: Zinc Oxide
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zinc oxide sticking tablets at the same acupoints
Trial: 8217176
Drug: 16 mg
RxNorm normalized name: escin 16 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 mg of ondansetron
Trial: 27066461
Drug: Continuous antibiotic
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous antibiotic prophylaxis (CAP)
Trial: 21429706
Drug: Home-based constraint-induced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based constraint-induced therapy (CIT)
Trial: 21429706
Drug: Dose-matched home-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-matched home-based control intervention
Trial: 6400709
Drug: Acarbose 100
RxNorm normalized name: acarbose 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose 100 mg before the evening meal
Trial: 3915888
Drug: Tenoxicam 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenoxicam 40 mg/day
Trial: 3915888
Drug: Piroxicam 40
RxNorm normalized name: piroxicam 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam 40 mg/day
Trial: 28735464
Drug: High-dose protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose protocol
Trial: 28735464
Drug: Low-dose protocol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose protocol
Trial: 24065010
Drug: Pump-only therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pump-only therapy (standard insulin pump)
Trial: 18294116
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment with perindopril and indapamide
Trial: 11808057
Drug: 10% chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% chlorhexidine varnish treatment
Trial: 9209249
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg glyburide
Trial: 9209249
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg minoxidil with 2.5 mg glyburide
Trial: 17628384
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg glyburide
Trial: 9209249
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg glyburide with 5 mg minoxidil
Trial: 31096794
Drug: Microneedling with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microneedling with topical bleomycin at 2 weeks interval
Trial: 1640303
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no antibiotic treatment)
Trial: 3513752
Drug: Methamphetamine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methamphetamine (20 mg)
Trial: 19916063
Drug: Methamphetamine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methamphetamine (40 mg)
Trial: 1971862
Drug: Gabapentin 1200
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin 1200 mg/day
Trial: 11690735
Drug: Gabapentin 1800
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin 1800 mg/day
Trial: 16879931
Drug: Gabapentin 2400
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin 2400 mg/day
Trial: 18070144
Drug: Control (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (250 ml of 0.9% sodium chloride)
Trial: 16480969
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy alone in Group B
Trial: 16480969
Drug: Atorvastatin vs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin vs Conventional therapy alone
Trial: 8924191
Drug: Phentermine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phentermine (30 mg)
Trial: 4317858
Drug: Fenfluramine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenfluramine (40 mg)
Trial: 8924191
Drug: d-Amphetamine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-Amphetamine (10 mg)
Trial: 3933028
Drug: d-Amphetamine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-Amphetamine (20 mg)
Trial: 8924191
Drug: Fenfluramine (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenfluramine (80 mg)
Trial: 24377403
Drug: Psychological therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychological therapies (Cognitive Behavioral Therapy and Psychoanalytic Therapy)
Trial: 22094261
Drug: Preemptive morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preemptive morphine analgesia (maximum of 14 days)
Trial: 15100699
Drug: Lamotrigine (LTG)
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine (LTG) 325 mg
Trial: 12387693
Drug: Antibiotics (specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics (specific type not mentioned)
Trial: 2008942
Drug: Ropivacaine 0.5%
RxNorm normalized name: ROPivacaine 0.5% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.5% (175 mg)
Trial: 2008942
Drug: Bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.5% (175 mg)
Trial: 7261830
Drug: Antacid foam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacid foam tablets
Trial: 24089377
Drug: Beetroot juice
RxNorm normalized name: tamarind juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beetroot juice (BR) supplementation (140 ml/day, containing 8 mmol of NO3(‐))
Trial: 18505948
Drug: Problem-solving therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem-solving therapy
Trial: 17915638
Drug: Helicidum tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Helicidum tablet preparation 2 (75 mg, 3 tablets)
Trial: 25204507
Drug: 0.5 μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 μg/kg of dexmedetomidine (subclinical dose group)
Trial: 25204507
Drug: 1.0 μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 μg/kg of dexmedetomidine (clinical dose group)
Trial: 11049764
Drug: Amoxicillin/clavulanate
RxNorm normalized name: AMOXICILLIN/CLAVULANATE
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate
Trial: 27151024
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human thrombopoietin (rhTPO) at a dose of 300 U/(kg·d) for a maximum of 14 days
Trial: 27151024
Drug: Glucocorticoid (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucocorticoid (standard dose) for 28 days
Trial: 17721372
Drug: Epaxal coadministered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epaxal coadministered with DTPaHibIPV, oral polio vaccine, and measles‐mumps‐rubella vaccine (group A)
Trial: 17721372
Drug: Havrix Junior
RxNorm normalized name: Havrix
DrugBank: Hepatitis A Vaccine (DB10989)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Havrix Junior coadministered with DTPaHibIPV, oral polio vaccine, and measles‐mumps‐rubella vaccine (group C)
Trial: 17721372
Drug: Booster dose
RxNorm normalized name: SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna) 50 MCG/0.5 ML Intramuscular Suspension [MODERNA COVID-19 VACCINE BOOSTER DOSE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster dose for all groups
Trial: 15298633
Drug: Esomeprazole 20
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 20 mg twice daily
Trial: 22700038
Drug: MDMA (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDMA (125 mg)
Trial: 30942011
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (conventional treatment only).
Trial: 26156796
Drug: Butyrate enema
RxNorm normalized name: butyrate
DrugBank: Butyric Acid (DB03568)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butyrate enema (100 mmol sodium butyrate/L; 60 mL; n = 7)
Trial: 26156796
Drug: Placebo (140
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (140 mmol 0.9% NaCl/L; 60 mL; n = 5)
Trial: 22496275
Drug: Preventive medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive medications (statins, antiplatelet therapy, beta-blockers, ACE inhibitors/ARBs)
Trial: 21899544
Drug: Methylsulfonylmethane (MSM)
DrugBank: Dimethyl sulfone (DB14090)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylsulfonylmethane (MSM) supplementation (50 mg/kg body weight)
Trial: 18179672
Drug: Schema Focused
RxNorm normalized name: AVOBENZONE 0.2 g in 1 g / BUTYLENE GLYCOL 0.1 g in 1 g TOPICAL CREAM [Focused Corrective]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Schema Focused Therapy (SFT)
Trial: 10808734
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate 10 mg
Trial: 11070759
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate 40 mg-SR
Trial: 11070759
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate 80 mg-SR
Trial: 1571421
Drug: Renal ultrasonography
RxNorm normalized name: Sus scrofa renal pelvis preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Renal ultrasonography after antimicrobial therapy
Trial: 31335641
Drug: Hybrid emotion-focused
RxNorm normalized name: Amaranthus hybridus pollen
DrugBank: Amaranthus hybridus pollen (DB15503)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid emotion-focused exposure treatment (n = 58, 10-16 sessions)
Trial: 31335641
Drug: iCBT (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iCBT (n = 57; 8 treatment modules)
Trial: 30113526
Drug: Perindopril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (10 mg daily)
Trial: 12937228
Drug: Amlodipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (5 mg daily)
Trial: 22901886
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg mepolizumab
Trial: 18085837
Drug: IANB plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IANB plus mock buccal infiltration and lingual infiltration
Trial: 16260891
Drug: Indomethacin (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (0.2 mg/kg, three doses at 12-hour intervals, infused continuously over 15 min)
Trial: 16260891
Drug: Ibuprofen (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (10 mg/kg initial dose followed by two doses of 5 mg/kg each after 24 and 48 h, infused continuously over 15 min)
Trial: 12226782
Drug: Real ESWT
RxNorm normalized name: REAL FOODS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Real ESWT (low-energy shock wave therapy)
Trial: 11382863
Drug: Cholinergic REM
RxNorm normalized name: carbamide peroxide
DrugBank: Carbamide peroxide (DB11129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cholinergic REM sleep induction test (CRIT) with 10 mg galanthamine
Trial: 25488686
Drug: docetaxel (35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: docetaxel (35 mg/m² days 1, 8, 15 every 4 weeks for four or six cycles)
Trial: 25488686
Drug: CMF (cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMF (cyclophosphamide 600 mg/m², methotrexate 40 mg/m², fluorouracil 600 mg/m², days 1, 8)
Trial: 23352187
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (NS) injection plus PT
Trial: 20919993
Drug: Selective iNOS
RxNorm normalized name: Inositol
DrugBank: Inositol (DB13178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Selective iNOS inhibitor 1400W
Trial: 19698147
Drug: Drug (positive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug (positive control) group
Trial: 16424063
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea catechins (GTCs) - 600 mg/d (three capsules of 200 mg each)
Trial: 30024811
Drug: Community Health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community Health Worker (CHW) intervention with cash incentives, supply chain support, and monthly clinical supervision.
Trial: 19879276
Drug: Ceftriaxone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone (1 x 2 g daily for 14 days)
Trial: 19879276
Drug: Meropenem (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem (3 x 1 g daily for 14 days)
Trial: 16238119
Drug: Novo‐Helisen Depot
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novo‐Helisen Depot allergy vaccines for 3 years
Trial: 16238119
Drug: Conventional methods
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional methods of treatment
Trial: 10524722
Drug: Cognitive-behavioural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural therapy over a period of 8 weeks
Trial: 10524722
Drug: No changes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No changes to treatment status (Control)
Trial: 30318240
Drug: USG-guided SLN
RxNorm normalized name: naphazoline
DrugBank: Naphazoline (DB06711)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: USG-guided SLN block bilaterally with 2.5 ml of 2% lignocaine along with GA (Group L)
Trial: 27802910
Drug: Support therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Support therapy group (SG)
Trial: 16460486
Drug: Silybum marianum
RxNorm normalized name: Silybum marianum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silybum marianum (600 mg or 1200 mg/day)
Trial: 11571244
Drug: alpha‐galactosidase A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha‐galactosidase A therapy
Trial: 9610942
Drug: Zolpidem 10
RxNorm normalized name: zolpidem 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem 10 mg with alcohol (0.75 g ethanol/kg b.wt.)
Trial: 9610942
Drug: Zolpidem 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem 15 mg with alcohol (0.75 g ethanol/kg b.wt.)
Trial: 9610942
Drug: Zolpidem with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem with alcohol (0.75 g ethanol/kg b.wt.)
Trial: 7821190
Drug: 4 injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 injections per day with a pen injector
Trial: 26520004
Drug: Modafinil 200
RxNorm normalized name: modafinil 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil 200 mg
Trial: 21153402
Drug: Immunoparalysis (TNFα
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunoparalysis (TNFα response <200 pg/mL)
Trial: 14532998
Drug: One arterial
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One arterial infusion of cisplatin
Trial: 11070752
Drug: Moclobemide (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide (maximum dose 600 mg per day)
Trial: 11070752
Drug: Amitriptyline (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (maximum dose 150 mg per day)
Trial: 8968702
Drug: Fermented milk
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fermented milk product (200 ml daily)
Trial: 8968702
Drug: Placebo (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (200 ml daily)
Trial: 1621746
Drug: Amoxicillin/clavulanate (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate (500 mg three times daily)
Trial: 7570411
Drug: Amoxicillin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (500 mg three times daily)
Trial: 24454970
Drug: Multiple doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple doses of AmBisome (7 times 3 mg/kg on days 1-5, 14, and 21)
Trial: 24454970
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of AmBisome 10 mg/kg
Trial: 24454970
Drug: Multiple doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple doses of AmBisome
Trial: 10385721
Drug: Terlipressin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terlipressin (2 mg)
Trial: 18058622
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin D3 supplementation (1000 IU per orally five days per week for 10 weeks)
Trial: 16219099
Drug: Implementation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implementation of pre-hospital emergency pathway (training module and administration of the guideline)
Trial: 3139830
Drug: Flunarizine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunarizine (20 mg)
Trial: 26867076
Drug: Sertraline therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline therapy (50-200 mg daily)
Trial: 24582532
Drug: Vitamin K
RxNorm normalized name: Vitamin K
DrugBank: Phylloquinone (DB01022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin K antagonist use
Trial: 20456735
Drug: Therapeutic dose
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic dose (60 mg)
Trial: 10551154
Drug: Scaling with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scaling with adjunctive antimicrobial therapy
Trial: 10512386
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups received supportive periodontal therapy at 3, 6, 9, 12, 18, and 24 months
Trial: 782679
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate aerosol (BDA), 50 mug four times daily in each nostril
Trial: 16936418
Drug: Combined intravenous
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined intravenous and intracoronary administration of nicorandil (Group B)
Trial: 16936418
Drug: No nicorandil
RxNorm normalized name: nicorandil
DrugBank: Nicorandil (DB09220)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No nicorandil administration (Group C)
Trial: 4044346
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose per fraction radiotherapy at 9 Gy X 3
Trial: 4044346
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose per fraction radiotherapy at 5 Gy X 8 twice weekly
Trial: 27871505
Drug: Sugammadex (2-4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex (2-4 mg · kg‐1) after deep neuromuscular block with 0.6 mg · kg‐1 rocuronium
Trial: 27871505
Drug: Neostigmine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine (50 μg · kg‐1) after shallow neuromuscular block with 0.45 mg · kg‐1 rocuronium
Trial: 27871505
Drug: Sugammadex (2-4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex (2-4 mg · kg‐1)
Trial: 27871505
Drug: Neostigmine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine (50 μg · kg‐1)
Trial: 22820319
Drug: Palivizumab (one-monthly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palivizumab (one-monthly intramuscular injections during RSV season, minimum of 2 injections)